Table of Content

1 Study Coverage
1.1 Vaccine Adjuvant Product Introduction
1.2 Market by Type
1.2.1 Global Vaccine Adjuvant Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Vaccine Adjuvant Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Vaccine Adjuvant Market by Region
1.4.1 Global Vaccine Adjuvant Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Vaccine Adjuvant Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Vaccine Adjuvant Revenue by Players
2.1.1 Global Vaccine Adjuvant Revenue by Players (2019-2024)
2.1.2 Global Vaccine Adjuvant Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Vaccine Adjuvant Revenue in 2024
2.2 Global Vaccine Adjuvant Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Vaccine Adjuvant Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 GlaxoSmithKline
3.1.1 GlaxoSmithKline Information
3.1.2 GlaxoSmithKline Overview
3.1.3 GlaxoSmithKline Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.1.4 GlaxoSmithKline Related Developments
3.2 Novavax
3.2.1 Novavax Information
3.2.2 Novavax Overview
3.2.3 Novavax Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.2.4 Novavax Related Developments
3.3 SPI Pharma
3.3.1 SPI Pharma Information
3.3.2 SPI Pharma Overview
3.3.3 SPI Pharma Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.3.4 SPI Pharma Related Developments
3.4 Agenus
3.4.1 Agenus Information
3.4.2 Agenus Overview
3.4.3 Agenus Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.4.4 Agenus Related Developments
3.5 CSL Limited
3.5.1 CSL Limited Information
3.5.2 CSL Limited Overview
3.5.3 CSL Limited Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.5.4 CSL Limited Related Developments
3.6 InvivoGen
3.6.1 InvivoGen Information
3.6.2 InvivoGen Overview
3.6.3 InvivoGen Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.6.4 InvivoGen Related Developments
3.7 Brenntag Biosector
3.7.1 Brenntag Biosector Information
3.7.2 Brenntag Biosector Overview
3.7.3 Brenntag Biosector Vaccine Adjuvant Revenue and Gross Margin (2019-2024)
3.7.4 Brenntag Biosector Related Developments
4 Market Size by Type
4.1 Global Vaccine Adjuvant Revenue by Type
4.2 Global Vaccine Adjuvant Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Vaccine Adjuvant Revenue by Application
5.2 Global Vaccine Adjuvant Market Size Growth by Application 2019-2024
6 Global Vaccine Adjuvant Market Insights
6.1 Global Vaccine Adjuvant Market Revenue 2019-2024
6.2 Global Vaccine Adjuvant Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Vaccine Adjuvant Market Size by Country
7.1.1 Americas Vaccine Adjuvant Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Vaccine Adjuvant Market Size by Country
8.1.1 Europe Vaccine Adjuvant Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Vaccine Adjuvant Market Size by Region
9.1.1 Asia Pacific Vaccine Adjuvant Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Adjuvant Market Size by Country
10.1.1 Middle East and Africa Vaccine Adjuvant Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Vaccine Adjuvant Industry Trends
11.2 Vaccine Adjuvant Market Drivers
11.3 Vaccine Adjuvant Market Challenges
11.4 Vaccine Adjuvant Market Restraints
12 Vaccine Adjuvant Forecasted Market Size by Type
12.1 Global Vaccine Adjuvant Forecasted Revenue by Type
12.2 Global Vaccine Adjuvant Forecasted Market Size Growth by Type 2024-2030
13 Vaccine Adjuvant Forecasted Market Size by Application
13.1 Global Vaccine Adjuvant Forecasted Revenue by Application
13.2 Global Vaccine Adjuvant Forecasted Market Size Growth by Application 2024-2030
14 Global Vaccine Adjuvant Market Forecasts
14.1 Global Vaccine Adjuvant Market Revenue Forecasts 2024-2030
14.2 Global Vaccine Adjuvant Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Vaccine Adjuvant Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Vaccine Adjuvant Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Vaccine Adjuvant Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Vaccine Adjuvant Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer